Literature DB >> 8780913

Characteristics of familial ovarian cancer: a report of the first 1,000 families in the Gilda Radner Familial Ovarian Cancer Registry.

M S Piver1, J M Goldberg, Y Tsukada, C J Mettlin, M F Jishi, N Natarajan.   

Abstract

BACKGROUND: To determine the demographics of the first 1,000 families in the Gilda Radner Familial Ovarian Cancer Registry.
METHODS: Any woman with a family history of two or more first or second degree relatives with ovarian cancer who was referred to the Registry was entered into a database. The demographics of the Registry population were analyzed, including total number of ovarian cancer cases, cases per family, age at diagnosis, prevalence of other malignancies, and histology. Comparisons were made to expected norms in the general population using the most recent surveillance, Epidemiology, and End Results data from the National Cancer Institute.
RESULTS: There were 2,425 reported cases of ovarian cancer among the 1,000 registered families. The number of cases per family ranged from 2-10 with 72.4% of the families having two cases of ovarian cancer and 27.6% with three or more cases of ovarian cancer. The mean age at diagnosis was 53.5 years, significantly younger than the 60.8 years reported in the general population (p < 0.1). The mean age at diagnosis was even younger, 52.1 years, in the subset of patients with a family history of three or more cases of ovarian cancer. Moreover, in the mother/daughter pairs of ovarian cancer where age of onset of ovarian cancer was known, the mean age of the mothers was 58.8 compared to a mean age of 50.2 among the daughters (p < 0.01). There was a significantly larger proportion of serous adenocarcinoma (40%) and a significantly smaller proportion of mucinous adenocarcinoma (3%) and stromal cell tumor (0%) when compared to the general population (p < 0.01). Breast and colon cancer were the two most common other cancers reported.
CONCLUSIONS: given the limits of the study due to the voluntary nature of the Registry, the data suggests that familial ovarian cancer occurs at a younger age than the general population, daughters of mothers with ovarian cancers develop ovarian cancer at an age significantly younger than their mothers, mucinous and stromal tumors occurred significantly less often than in the general population, and the most common associated other cancers are female breast cancer and female and male colon cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8780913

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  5 in total

1.  Qualitative Evaluation of Medical Information Processing Needs of 60 Women Choosing Ovarian Cancer Surveillance or Prophylactic Oophorectomy.

Authors:  Sheri A Babb; Elizabeth M Swisher; Hope N Heller; Alison J Whelan; David G Mutch; Thomas J Herzog; Janet S Rader
Journal:  J Genet Couns       Date:  2002-04       Impact factor: 2.537

Review 2.  Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

Authors:  Henry T Lynch; Murray Joseph Casey; Carrie L Snyder; Chhanda Bewtra; Jane F Lynch; Matthew Butts; Andrew K Godwin
Journal:  Mol Oncol       Date:  2009-02-21       Impact factor: 6.603

3.  Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Liaquat Ali; Shashikant Lele; Michael A Huba; Song Liu; Kunle Odunsi
Journal:  Cancer Immun       Date:  2013-01-15

4.  Higher than expected frequencies of non-ovarian cancers within a large familial ovarian cancer registry.

Authors:  Rachel M Brightwell; Kassondra S Grzankowski; Jasmine Kaur; Samantha Poblete; Austin Miller; Shashikant B Lele; Lara Sucheston-Campbell; Kirsten Moysich; Kunle O Odunsi
Journal:  Am J Clin Exp Obstet Gynecol       Date:  2015-02-15

5.  Complex segregation analysis of pedigrees from the Gilda Radner Familial Ovarian Cancer Registry reveals evidence for mendelian dominant inheritance.

Authors:  Bamidele O Tayo; Richard A DiCioccio; Yulan Liang; Maurizio Trevisan; Richard S Cooper; Shashikant Lele; Lara Sucheston; Steven M Piver; Kunle Odunsi
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.